
Stiefel, a global leader in skin health treatment and research, is passionate about improving the lives of people affected by skin conditions. Stiefel has a long history of excellence in dermatology and deep expertise and R&D capabilities in acne, psoriasis, eczema, atopic dermatitis and superficial skin infections.
Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.